Teacher Retirement System of Texas grew its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 14.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,240 shares of the life sciences company’s stock after purchasing an additional 532 shares during the period. Teacher Retirement System of Texas’ holdings in Illumina were worth $845,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of ILMN. Advisory Services Network LLC raised its stake in Illumina by 13.0% during the second quarter. Advisory Services Network LLC now owns 772 shares of the life sciences company’s stock valued at $134,000 after purchasing an additional 89 shares in the last quarter. Penserra Capital Management LLC grew its holdings in shares of Illumina by 13.0% in the second quarter. Penserra Capital Management LLC now owns 884 shares of the life sciences company’s stock worth $153,000 after purchasing an additional 102 shares during the last quarter. Dupont Capital Management Corp bought a new position in shares of Illumina in the third quarter worth about $153,000. Paradigm Asset Management Co. LLC grew its holdings in Illumina by 5.6% during the 2nd quarter. Paradigm Asset Management Co. LLC now owns 950 shares of the life sciences company’s stock worth $165,000 after acquiring an additional 50 shares in the last quarter. Finally, NN Investment Partners Holdings N.V. grew its holdings in Illumina by 11.3% during the 2nd quarter. NN Investment Partners Holdings N.V. now owns 985 shares of the life sciences company’s stock worth $171,000 after acquiring an additional 100 shares in the last quarter. 91.75% of the stock is owned by institutional investors and hedge funds.
Illumina, Inc. (NASDAQ ILMN) traded up $0.69 on Thursday, hitting $214.67. The stock had a trading volume of 682,331 shares, compared to its average volume of 955,885. The company has a market cap of $31,510.00, a P/E ratio of 61.71, a PEG ratio of 3.49 and a beta of 0.79. The company has a quick ratio of 3.73, a current ratio of 4.22 and a debt-to-equity ratio of 0.41. Illumina, Inc. has a 12 month low of $120.00 and a 12 month high of $230.72.
Illumina (NASDAQ:ILMN) last issued its quarterly earnings results on Tuesday, October 24th. The life sciences company reported $1.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.12. The business had revenue of $714.00 million for the quarter, compared to the consensus estimate of $692.77 million. Illumina had a return on equity of 19.42% and a net margin of 30.34%. Illumina’s revenue for the quarter was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 earnings per share. research analysts expect that Illumina, Inc. will post 3.75 earnings per share for the current fiscal year.
Several equities analysts recently commented on the stock. BidaskClub lowered shares of Illumina from a “buy” rating to a “hold” rating in a research report on Wednesday. Zacks Investment Research upgraded shares of Illumina from a “hold” rating to a “buy” rating and set a $252.00 price target on the stock in a research note on Tuesday. Citigroup upped their price target on Illumina from $180.00 to $220.00 and gave the company a “neutral” rating in a report on Wednesday, October 25th. Barclays boosted their price objective on Illumina from $150.00 to $185.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 25th. Finally, Bank of America boosted their price objective on Illumina from $215.00 to $240.00 and gave the company a “buy” rating in a research note on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $201.98.
In other Illumina news, SVP Charles Dadswell sold 145 shares of the business’s stock in a transaction that occurred on Tuesday, October 3rd. The shares were sold at an average price of $202.23, for a total transaction of $29,323.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jay T. Flatley sold 20,000 shares of the company’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $211.11, for a total transaction of $4,222,200.00. Following the transaction, the director now owns 539,176 shares in the company, valued at approximately $113,825,445.36. The disclosure for this sale can be found here. Over the last quarter, insiders sold 166,150 shares of company stock worth $34,767,331. Corporate insiders own 0.89% of the company’s stock.
TRADEMARK VIOLATION WARNING: This story was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at https://www.dispatchtribunal.com/2017/12/07/illumina-inc-ilmn-shares-bought-by-teacher-retirement-system-of-texas.html.
Illumina Company Profile
Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.
Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.